Protocol No
IIT-WONG-ATB-RANDOMIZED
Staff Member
Stuart J Wong
Phase
Early Phase I
Summary
This research study is being conducted to determine the effectiveness of Antitumor B (ATB), a botanical agent composed of six Chinese herbs, to slow down tumor growth. ATB is still experimental, meaning it is not approved by the U.S. Food and Drug Administration (FDA). We do not know all the ways that this compound may affect people
Objective
IIT-WONG-ATB-RANDOMIZED
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov